Infrastucture for CER on Innovative Delivery Systems for Complex Patients

针对复杂患者的创新输送系统的 CER 基础设施

基本信息

  • 批准号:
    8020258
  • 负责人:
  • 金额:
    $ 98.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-30 至 2013-09-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This project will establish a statewide data infrastructure for Comparative Effectiveness Research (CER) on healthcare delivery innovations for complex patients in low-income communities. It addresses two CER priorities established by the Institute of Medicine in 2009 to evaluate outcomes of: (1) "...comprehensive care coordination programs, such as the medical home, in managing children and adults with severe chronic disease, especially in populations with known health disparities"; and (2) "accountable care systems ...for geographically defined populations of patients with one or more chronic diseases." Responding to the Agency for Healthcare Research and Quality request for applications (RFA-HS-10-001) to expand research capability to study comparative effectiveness in complex patients, this project has three specific aims: 1. Build a sustainable longitudinal database of linked hospital, Medicaid, and charity care claims and encounter records in New Jersey for CER on strategies to improve the delivery of care to complex patients in low-income communities. 2. Build and evaluate measures of resource use and quality of care for CER on innovative delivery systems for complex patients in low-income communities using the database developed under Aim 1. 3. Demonstrate the potential of this new research infrastructure by conducting a pilot evaluation of health services resource use and quality for complex patients served by an innovative care coordination program in Camden, NJ. Designed to become an ongoing enterprise, the data infrastructure will initially consist of six years of state program administrative records. Products of this work will be disseminated widely and the database will be released for public use. The project builds on a long-standing collaboration between university researchers and agencies of New Jersey government, and will take place in the context of state policies encouraging innovation in health care delivery for low-income urban populations. New Jersey is especially well suited to CER on health system delivery innovations because it has exceptionally high rates of preventable utilization of expensive hospital care. PUBLIC HEALTH RELEVANCE: Patients with complex health conditions in low-income communities frequently experience inadequate and fragmented health services, leading to avoidable use of expensive hospital care and poor outcomes. This project will build research capacity to compare the cost and quality of health care delivery system innovations to care typically received by medically complex patients in low-income communities in New Jersey.
描述(由申请人提供):该项目将建立针对低收入社区中复杂患者的医疗保健交付创新的比较有效性研究(CER)的全州数据基础架构。它涉及医学研究所于2009年建立的两个CER优先事项,以评估以下情况:(1)“……综合护理协调计划,例如医疗之家,管理严重慢性病的儿童和成年人,尤其是在患有已知健康差异的人群中”; (2)“负责任的护理系统...对于一种或多种慢性疾病的患者的地理定义人群。”回应医疗保健研究和质量应用程序的质量要求(RFA-HS-10-001),以扩大研究能力,以研究复杂患者的比较有效性,该项目具有三个具体的目的:1。建立可持续的纵向数据库,链接的医院,医疗补助和慈善机构护理索赔和慈善保健索赔和遇到新泽西州的记录以改善策略以改善策略患者,以改善较低的服务。 2.使用AIM1。3。3。通过在AIM1。3中开发的数据库为复杂患者的CER的资源使用和护理质量的衡量标准。通过对Campen camden,NJ,NJ,Intovative Careing Coortination in Innovative Careotination进行复杂的患者,通过对复杂患者为复杂的患者提供了对健康服务资源使用和质量的试点评估,证明了这项新的研究基础架构的潜力。旨在成为一家持续的企业,数据基础架构最初将由六年的国家计划管理记录组成。这项工作的产品将被广泛传播,并且数据库将被发布供公众使用。该项目建立在大学研究人员与新泽西政府机构之间的长期合作的基础上,并将在州政策的背景下进行,鼓励低收入城市人口的医疗保健提供创新。新泽西州特别适合CER进行卫生系统交付创新,因为它具有昂贵的医院护理的可预防利用率。 公共卫生相关性:低收入社区中健康状况复杂的患者经常经历不足和分散的健康服务,从而避免使用昂贵的医院护理和不良的结果。该项目将建立研究能力,将医疗保健提供系统创新的成本和质量与新泽西州低收入社区医学复杂患者通常接受的护理相比。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Statistical uncertainty in the Medicare shared savings program.
  • DOI:
    10.5600/mmrr.002.04.a04
  • 发表时间:
    2012-01-01
  • 期刊:
  • 影响因子:
    0
  • 作者:
    DeLia, Derek;Hoover, Donald;Cantor, Joel C
  • 通讯作者:
    Cantor, Joel C
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOEL C CANTOR其他文献

JOEL C CANTOR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOEL C CANTOR', 18)}}的其他基金

The Role of Homelessness and Supportive Housing in Healthcare Disparities among Adults in Medicaid
无家可归和支持性住房在医疗补助成年人医疗保健差异中的作用
  • 批准号:
    10576952
  • 财政年份:
    2021
  • 资助金额:
    $ 98.38万
  • 项目类别:
The Role of Homelessness and Supportive Housing in Healthcare Disparities among Adults in Medicaid
无家可归和支持性住房在医疗补助成年人医疗保健差异中的作用
  • 批准号:
    10408776
  • 财政年份:
    2021
  • 资助金额:
    $ 98.38万
  • 项目类别:
The Role of Homelessness and Supportive Housing in Healthcare Disparities among Adults in Medicaid
无家可归和支持性住房在医疗补助成年人医疗保健差异中的作用
  • 批准号:
    10206880
  • 财政年份:
    2021
  • 资助金额:
    $ 98.38万
  • 项目类别:
Regulatory Reform and Angiography Disparties
监管改革与血管造影的分歧
  • 批准号:
    6762648
  • 财政年份:
    2004
  • 资助金额:
    $ 98.38万
  • 项目类别:
Regulatory Reforn and Angiography Disparties
监管改革和血管造影的分歧
  • 批准号:
    7113197
  • 财政年份:
    2004
  • 资助金额:
    $ 98.38万
  • 项目类别:
Regulatory Reforn and Angiography Disparties
监管改革和血管造影的分歧
  • 批准号:
    6924520
  • 财政年份:
    2004
  • 资助金额:
    $ 98.38万
  • 项目类别:

相似国自然基金

基于ADPN-Cer轴的柑橘黄酮调控能量负平衡奶牛脂肪组织脂解的分子机制
  • 批准号:
    32302767
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
CER(d18:1/18:1)与NDUFA6相互作用抑制RC-I介导的反向电子传递ROS生成在改善肝缺血再灌注损伤的作用及机制研究
  • 批准号:
    82270661
  • 批准年份:
    2022
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目
大麦叶鞘表皮蜡质β-二酮缺失突变体cer-b基因的图位克隆及功能分析
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
大麦叶鞘表皮蜡质β-二酮缺失突变体cer-b基因的图位克隆及功能分析
  • 批准号:
    32201813
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

LOSS-SAMPLER: Tools for quantifying and managing unseen volatility in CER portfolios
LOSS-SAMPLER:用于量化和管理 CER 投资组合中未见波动的工具
  • 批准号:
    10057920
  • 财政年份:
    2023
  • 资助金额:
    $ 98.38万
  • 项目类别:
    Small Business Research Initiative
LOSS-SAMPLER: A tool for identifying unseen volatility in present and future Climate and Environmental Risk (CER) portfolios
LOSS-SAMPLER:用于识别当前和未来气候和环境风险 (CER) 投资组合中未见波动的工具
  • 批准号:
    10030979
  • 财政年份:
    2022
  • 资助金额:
    $ 98.38万
  • 项目类别:
    Small Business Research Initiative
Dopamine vs. Norepinephrine for hypotension in very preterm infants with late-onset sepsis: A National Comparative Effectiveness Research (CER) Project
多巴胺与去甲肾上腺素治疗晚发败血症极早产儿低血压:国家比较有效性研究 (CER) 项目
  • 批准号:
    452101
  • 财政年份:
    2021
  • 资助金额:
    $ 98.38万
  • 项目类别:
    Operating Grants
Relative effectiveness and safety of pharmacotherapeutic agents for treatment of patent ductus arteriosus (PDA) in preterm infants: A National Comparative Effectiveness Research (CER) Project
药物治疗药物治疗早产儿动脉导管未闭 (PDA) 的相对有效性和安全性:国家比较有效性研究 (CER) 项目
  • 批准号:
    410247
  • 财政年份:
    2019
  • 资助金额:
    $ 98.38万
  • 项目类别:
    Operating Grants
HOD1: Comparative Effectiveness Research using Observational Data:Methodological Developments and a Roadmap (CER-OBS)
HOD1:使用观察数据的比较有效性研究:方法发展和路线图(CER-OBS)
  • 批准号:
    MR/R025215/1
  • 财政年份:
    2018
  • 资助金额:
    $ 98.38万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了